GEVO patents NKR variants for isobutanol production
USPTO Patent Grants - Biotech (C12N)
Summary
GEVO patents NKR variants for isobutanol production
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NKR variants for increased production of isobutanol
Grant US12595466B2 Kind: B2 Apr 07, 2026
Assignee
GEVO, INC.
Inventors
Christopher Smith, Timothy Hanly, Jeanne Benoit
Abstract
The present invention relates to recombinant microorganisms comprising at least one nucleic acid molecule encoding a ketol-acid reductoisomerase (KARI) or modified NADH-dependent variant thereof, wherein said KARI is at least about 60% identical to SEQ ID NO: 2. In various aspects of the invention, the recombinant microorganisms may comprise an isobutanol producing metabolic pathway and can be used in methods of making isobutanol.
CPC Classifications
C12P 7/16 C12N 9/0006 C12N 15/52 C12Y 101/01086
Filing Date
2021-03-05
Application No.
17909353
Claims
10
Related changes
Get daily alerts for USPTO Patent Grants - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.